A  

Magnesium sulfate given to women at risk of imminent preterm birth not only acts as a tocolytic but also reduces the incidence of cerebral palsy and severe motor dysfunction in preterm infants, providing a proven fetal neuroprotective effect [Costantine & Weiner, 2009, PMID 19622997; Doyle, 2012, PMID 22227787].